نتایج جستجو برای: hydroxyurea

تعداد نتایج: 3268  

جمالی , مانی, وحیدشاهی , کوروش, کرمی , حسن, کرمی , حسین, کوثریان , مهرنوش,

Background and Purpose: Cholelithiasis is a common problem among patients with homozygous major and intermediate β-thalassemia due to chronic hemolysis, ineffective erythropoesis and other factors that causes variety of side effects. Hydroxyurea (HU) decreases hemolysis by increasing HbF production in homozygous β-thalassemia patients. Up to now, there have not been evidences about relationsh...

Eishi Oskuie A, Oni Heris S, Valizadeh N,

This is a picture presentation of myeloproliferative disorder developing to longitudinal melanonychia as a side effect of hydroxyurea. Keywords: Melanonychia, hydroxyurea, side effect.

Journal: :genetics in the 3rd millennium 0
مرداویژ آل بویه mardavij alebouyeh فریده موسوی farideh mousavi حسین حداد دیلمی hossein haddad پروانه وثوق parvaneh vosough

background: many efforts have been undertaken until now to find an alternative approach to packed red cell tranfusion in major β-thalassemia. augmentation of fetal hemoglobin by hydroxyurea has proved to be less effective in this condition as compared to sickle cell anemia, probably due to molecular heterogeneity of the former disease. hydroxyurea efficacy and its relation to xmn1 polymorphism ...

Cancer is a fatal disease and relatively widespread in the world; Breast cancer is the most prevalent cancer among women. Hydroxyurea (HU) is a chemotherapy drug for the cure of cancer different types in patients, for example breast cancer, but has several defects, for to remove these problems in this study a nanoliposome (NL) suspension for Hydroxyurea (HU) delivery in breast cancer cell thera...

Journal: :iranian journal of blood and cancer 0
a ghasemi b keikhaei sj sayedi

background: hemoglobin s arises is the result of a point mutation (a-t) in the sixth codon on the -globin gene on chromosome 11 causing sickle cell anemia. the presence of fetal hemoglobin in infancy plays a relatively protective role for vaso-occlusive symptoms that are the major contributor for the morbidity and mortality among patients with sickle cell anemia. hydroxyurea, an s-phase-specif...

A Ghasemi, B Keikhaei, SJ Sayedi,

Background: Hemoglobin S arises is the result of a point mutation (A-T) in the sixth codon on the -globin gene on chromosome 11 causing sickle cell anemia. The presence of fetal hemoglobin in infancy plays a relatively protective role for vaso-occlusive symptoms that are the major contributor for the morbidity and mortality among patients with sickle cell anemia. hydroxyurea, an s-phase-specif...

Journal: :Annals of dermatology 2009
Seon-Wook Hwang Soon-Kwon Hong Sang-Hyun Kim Jong-Keun Seo Deborah Lee Ho-Suk Sung

Hydroxyurea is a cytostatic agent that has recently become the drug of choice in the treatment of various myeloproliferative diseases. The cutaneous side effects of hydroxyurea include xerosis, hyperpigmentation, nail discoloration, and scaling. Leg ulcers have only rarely been reported in association with hydroxyurea treatment. A 75-year-old woman presented with leg ulcers, nail discoloration,...

Journal: :iranian journal of blood and cancer 0
valizadeh n eishi oskuie a oni heris s

this is a picture presentation of myeloproliferative disorder developing to longitudinal melanonychia as a side effect of hydroxyurea. keywords: melanonychia, hydroxyurea, side effect.

Journal: :Archives of dermatology 2010
Andrew H Kalajian Sarah Josephson Cely Janine C Malone Jyoti B Burruss Jeffrey P Callen

BACKGROUND Chronic hydroxyurea therapy is associated with numerous cutaneous adverse effects. While hydroxyurea-associated nonmelanoma skin cancers are known to be associated with significant morbidity and occasional mortality, to date, dermatomyositis-like eruption has been considered a benign entity, other than its ability to mimic true dermatomyositis leading to inappropriate immunosuppressi...

Journal: :Archives of dermatology 2001
B Chaine M G Neonato R Girot S Aractingi

BACKGROUND Treatment with hydroxyurea may alleviate the symptoms of sickle cell disease (SCD). Because treatment with hydroxyurea may be responsible for several cutaneous side effects and is often lifelong in patients with SCD, we conducted this study to evaluate the risk of cutaneous adverse reactions in SCD patients treated with hydroxyurea. OBSERVATIONS Seventeen adult patients with SCD tr...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید